#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukoencephalopathy Spina bifida Colon cancer Cerebral arteriovenous malformation haemorrhagic Hypergammaglobulinaemia benign monoclonal B-cell small lymphocytic lymphoma refractory Synovial sarcoma Measles White matter lesion Non-renal cell carcinoma of kidney Nephrotic syndrome Multifocal motor neuropathy B-cell small lymphocytic lymphoma recurrent Adenoid cystic carcinoma Scleroderma associated digital ulcer More trials…

    Learn about Rare Diseases

    Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment MELAS syndrome – Basic Information Osteosarcoma recurrent – Diagnostics Progressive supranuclear palsy – Basic Information Sjogren’s syndrome – Trials in Disease Haemolytic uraemic syndrome – Life with Disease Immunodeficiency congenital – Diagnostics Focal segmental glomerulosclerosis – Diagnostics Piriformis syndrome – Life with Disease Leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Copper (64Cu) Chloride Tradipitant Abc-24F-116 Abc-23A-116 Cefotaxime Sodium Citalopram Bi 765845 Vildagliptin Munc-T3 Hct116-A GSKVX000000070965 ALLERGEN EXTRACTS Avelumab Quinidine Sulfate Enzalutamide Rivaroxaban Sarilumab Potassium Oxybate Glibenclamide Human Coagulation Factor Viii More therapies…

    Learn about Your Condition

    Adenocarcinoma of colon Apheresis Kidney transplant rejection Agitation postoperative Juvenile spondyloarthritis Carpal tunnel syndrome Demyelination Haemophilia Papillary thyroid cancer Inflammatory bowel disease Vulvar dysplasia Behavioural addiction Cough Neurogenic bladder Acute promyelocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut de Cancérologie Hématologie Universitaire…

Institut de Cancérologie Hématologie Universitaire de Saint Etienne (iCHUSE)

Avenue Albert Raimond, Saint Priest En Jarez, 42270, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    • Rectal cancer
    Investigated Drugs:
    • Cetuximab
    • Encorafenib
    France

  • Study on Dexamethasone for Patients with Advanced Relapsed or Refractory Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Dexamethasone
    France

  • Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Premature rupture of membranes
    Investigated Drugs:
    • Nifedipine
    France

  • Study on the Safety of Trifluridine/Tipiracil for Patients with Dihydropyrimidine Dehydrogenase Deficiency and Metastatic Colorectal or Gastroesophageal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Gastrooesophageal cancer
    Investigated Drugs:
    • Panitumumab
    • Tipiracil
    • Tipiracil Hydrochloride
    France

  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Myeloproliferative neoplasm
    • Polycythaemia vera
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Apixaban
    • Rivaroxaban
    France

  • Study on the Effects of Amikacin Sulfate and Protective Isolation in Critically Ill Neutropenic Patients with Sepsis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neutropenia
    • Critical illness
    Investigated Drugs:
    • Amikacin Sulfate
    France

  • Study of caspofungin compared to placebo for treating yeast infections in the abdomen in intensive care unit patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Fungal infection
    • Peritonitis
    Investigated Drugs:
    • Caspofungin
    • Sodium Chloride
    France

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Folinic Acid
    • Fluorouracil
    • Oxaliplatin
    France

  • Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Topotecan
    Austria Belgium Czechia France Germany Greece +7

  • Study on Atrasentan for Patients with IgA Nephropathy at Risk of Kidney Function Loss

    Recruiting

    3 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Atrasentan Hydrochloride
    • ZIGAKIBART
    France Germany Italy Poland Portugal Spain
Previous Page
1 … 9 10 11 12 13 … 46
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!